In fact, even some “techno-libertarians,” who believe that government should not regulate new developments in biotechnology, have supported the US Food and Drug Administration’s decision – outlined in a scathing letter to 23andMe CEO Anne Wojcicki last November – to prevent the firm from marketing its tests pending further scientific analysis. “I’d like to be able to argue that the [FDA] is wantonly standing in the way of entrepreneurism and innovation by cracking down on 23andMe,” wrote Matthew Herper in Forbes.
事实上，即使在认为政府不应该监管生物技术的新发展的“技术自由主义者”（techno-libertarians）中也有不少支持美国食品药品监督管理局（FDA）的决定——FDA给23andMe公司CEO安妮·沃伊西奇（Anne Wojcicki）寄了一封措辞严厉的公函，阻止该公司在后续科学分析期间推销其遗传测试服务。“我也十分希望能够指出[FDA]打击23andMe是在阻挠创业精神和创新，”马修·赫伯（Matthew Herper）在《福布斯》杂志中写道，“我希望我写的是这样的故事，但事实并非如此。”